Title : LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia - Liu_2020_Ann.Hematol_99_2343 |
Author(s) : Liu W , Burger JA , Xu J , Tang Z , Toruner G , Khanlari M , Medeiros LJ , Tang G |
Ref : Ann Hematol , 99 :2343 , 2020 |
Abstract : |
PubMedSearch : Liu_2020_Ann.Hematol_99_2343 |
PubMedID: 32833105 |